Study of blood gas composition and correction of treatment in patients with pulmonary hypertension on the background of chronic heart failure after COVID-19

IBRAGIMOV Ulug’bek Darxanovich., ADAYEV Abdugaffar Gadayevich., TURAKULOV Rustam Ismatullaevich., ABDUKHOLIKOV Oybek Ziyadullo ugli

dc.contributor.author	IBRAGIMOV Ulug’bek Darxanovich., ADAYEV Abdugaffar Gadayevich., TURAKULOV Rustam Ismatullaevich., ABDUKHOLIKOV Oybek Ziyadullo ugli
dc.date.accessioned	2022-12-12T19:57:32Z
dc.date.available	2022-12-12T19:57:32Z
dc.date.issued	2022
dc.identifier.citation	Тошкент	en_US
dc.identifier.issn	2181-9300
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/4837
dc.description.abstract	A number of literature reports on changes in the gas composition of the blood in patients with pulmonary hypertension, which developed on the basis of chronic heart failure. But the blood gases seen in this cohort of Covid-19 patients are not well understood. This article studied and analyzed in detail the blood gas content in patients with pulmonary hypertension, which developed against the background of chronic heart failure caused by Covid-19, before and after treatment with various components.	en_US
dc.language.iso	other	en_US
dc.subject	Covid-19, chronic heart failure, pulmonary hypertension, eplerenone, empagliflozin, blood gases.	en_US
dc.title	Study of blood gas composition and correction of treatment in patients with pulmonary hypertension on the background of chronic heart failure after COVID-19	en_US
dc.type	Article	en_US